Social Pharmacy Journal (SPJ)

Published by: Kowsar
Corrected Proof scheduled for 1 (2)

Evaluation of Physicians’ Knowledge, Attitude, and Practice on Pharmacoeconomics

Nazila Yousefi 1 , Farzad Peiravian 1 , Jamshid Salamzadeh 1 , * and Samira Mostashari 2
Authors Information
1 Department of Pharmacoeconomics and Pharma Management, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 International Branch of Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • Social Pharmacy Journal (SPJ): In Press (In Press); e59802
  • Published Online: September 30, 2016
  • Article Type: Research Article
  • Received: August 10, 2016
  • Accepted: September 7, 2016
  • DOI: 10.5812/spj.59802

To Cite: Yousefi N, Peiravian F, Salamzadeh J, Mostashari S. Evaluation of Physicians’ Knowledge, Attitude, and Practice on Pharmacoeconomics, Soc Pharm J. Online ahead of Print ; In Press(In Press):e59802. doi: 10.5812/spj.59802.

Abstract
Copyright © 2016, Social Pharmacy Journal (SPJ). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
Footnotes
References
  • 1. Vuorenkoski L, Toiviainen H, Hemminki E. Decision-making in priority setting for medicines--a review of empirical studies. Health Policy. 2008;86(1):1-9. doi: 10.1016/j.healthpol.2007.09.007. [PubMed: 17950484].
  • 2. Polak S, Skowron A, Mendyk A, Brandys J. Artificial neural network in pharmacoeconomics. Stud Health Technol Inform. 2004;105:241-9. [PubMed: 15718613].
  • 3. Hart J, Salman H, Bergman M, Neuman V, Rudniki C, Gilenberg D, et al. Do drug costs affect physicians' prescription decisions? J Intern Med. 1997;241(5):415-20. doi: 10.1046/j.1365-2796.1997.137143000.x. [PubMed: 9183310].
  • 4. Allan GM, Lexchin J, Wiebe N. Physician awareness of drug cost: a systematic review. PLoS Med. 2007;4(9). e283. doi: 10.1371/journal.pmed.0040283. [PubMed: 17896856]. [PubMed Central: PMC1989748].
  • 5. Ryan M, Yule B, Bond C, Taylor RJ. Do physicians' perceptions of drug costs influence their prescribing? Pharmacoeconomics. 1996;9(4):321-31. doi: 10.2165/00019053-199609040-00005. [PubMed: 10160106].
  • 6. Denig P, Haaijer-Ruskamp FM. Do physicians take cost into account when making prescribing decisions? Pharmacoeconomics. 1995;8(4):282-90. doi: 10.2165/00019053-199508040-00003. [PubMed: 10155670].
  • 7. Beran MS, Laouri M, Suttorp M, Brook R. Medication costs: the role physicians play with their senior patients. J Am Geriatr Soc. 2007;55(1):102-7. doi: 10.1111/j.1532-5415.2006.01011.x. [PubMed: 17233692].
  • 8. Kaliyaperumal K. Guideline for conducting a knowledge, attitude and practice (KAP) study. AECS Illumination. 2004;4(1):7-9.
  • 9. Watkins C, Harvey I, Carthy P, Moore L, Robinson E, Brawn R. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey. Qual Saf Health Care. 2003;12(1):29-34. doi: 10.1136/qhc.12.1.29. [PubMed: 12571342]. [PubMed Central: PMC1743655].
  • 10. Polinski JM, Maclure M, Marshall B, Cassels A, Agnew-Blais J, Patrick AR, et al. Does knowledge of medication prices predict physicians' support for cost effective prescribing policies. Can J Clin Pharmacol. 2008;15(2):e286-94. [PubMed: 18641423]. [PubMed Central: PMC2913604].
  • 11. Zwart-van Rijkom JE, Leufkens HG, Busschbach JJ, Broekmans AW, Rutten FF. Differences in attitudes, knowledge and use of economic evaluations in decision-making in The Netherlands. The Dutch results from the EUROMET Project. Pharmacoeconomics. 2000;18(2):149-60. doi: 10.2165/00019053-200018020-00005. [PubMed: 11067649].
  • 12. Awaisu A, Kheir N, Ibrahim MI, El-Hajj M, Hazi H, Khudair N, et al. Knowledge, attitudes, and practices of community pharmacists on generic medicines in Qatar. Int J Clin Pharm. 2014;36(2):394-404. doi: 10.1007/s11096-013-9909-2. [PubMed: 24532363].
  • 13. Moreno-Torres I, Puig-Junoy J, Raya JM. The impact of repeated cost containment policies on pharmaceutical expenditure: experience in Spain. Eur J Health Econ. 2011;12(6):563-73. doi: 10.1007/s10198-010-0271-1. [PubMed: 20809092].
  • 14. Ess SM, Schneeweiss S, Szucs TD. European healthcare policies for controlling drug expenditure. Pharmacoeconomics. 2003;21(2):89-103. doi: 10.2165/00019053-200321020-00002. [PubMed: 12515571].
  • 15. Buxton MJ. Economic evaluation and decision making in the UK. Pharmacoeconomics. 2006;24(11):1133-42. doi: 10.2165/00019053-200624110-00009. [PubMed: 17067197].
  • 16. Arenas-Guzman R, Tosti A, Hay R, Haneke E, National Institue for Clinical E. Pharmacoeconomics--an aid to better decision-making. J Eur Acad Dermatol Venereol. 2005;19 Suppl 1:34-9. doi: 10.1111/j.1468-3083.2005.01285.x. [PubMed: 16120204].
  • 17. Carthy P, Harvey I, Brawn R, Watkins C. A study of factors associated with cost and variation in prescribing among GPs. Fam Pract. 2000;17(1):36-41. doi: 10.1093/fampra/17.1.36. [PubMed: 10673486].
  • 18. Schumock GT, Walton SM, Park HY, Nutescu EA, Blackburn JC, Finley JM, et al. Factors that influence prescribing decisions. Ann Pharmacother. 2004;38(4):557-62. doi: 10.1345/aph.1D390. [PubMed: 14966259].
  • 19. Lexchin J. Improving the appropriateness of physician prescribing. Int J Health Serv. 1998;28(2):253-67. doi: 10.2190/ABWY-YFPA-ME5R-7BQP. [PubMed: 9595343].
  • 20. Fattore G, Torbica A. Economic evaluation in health care: the point of view of informed physicians. Value Health. 2006;9(3):157-67. doi: 10.1111/j.1524-4733.2006.00096.x. [PubMed: 16689709].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments